Results 41 to 50 of about 42,599 (163)
冠心病患者NT-ProBNP与HS-CRP联合检测的临床意义
Zhongguo shiyan zhenduanxue, 2006 目的探讨冠心病患者中NT-proBNP与hs-CRP联合检测的临床意义。方法收集临床上冠心病患者并进行分组,其中AMI组25例,UA组20例,SA组25例;正常对照组10例,所有患者入院后均即刻进行NT-proBNP与hs-CRP的检测,并根据NT-proBNP与hs-CRP高低再进一步将所有患者分成低NT-proBNP/低hs-CRP;低NT-proBNP/高hs-CRP;高NT-proBNP/低hs-CRP;高NT-proBNP/高hs-CRP四组。结果高NT-proBNP/高hs ...
宋春莉, 刘斌, 费瑜, 陈宏勃
doaj
Sensors, 2017 Cardiovascular diseases such as acute myocardial infarction and heart failure accounted for the death of 17.5 million people (31% of all global deaths) in 2015.
Keum-Soo Song +4 more
doaj +1 more source
BMC Infectious DiseasesBackground Up to 20% of COVID-19 patients can suffer COVID-19-related myocardial injury. Elevated cardiac biomarkers, such as hs-cTnT and NT-proBNP, have been related to worse short-term prognosis.
Diana Mojón-Álvarez +9 more
doaj +1 more source
The integration of BNP and NT-proBNP into clinical medicine
Swiss Medical Weekly, 2007 B-type natriuretic peptide (BNP) and NTproBNP have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are predominately secreted from the left and the right cardiac ventricle in response to volume and pressure overload.
Christian, Mueller +4 more
openaire +3 more sources
NT-proBNP for risk stratification of pulmonary embolism
Revista Portuguesa de Cardiologia (English Edition), 2011 Pulmonary embolism (PE) is an entity with high mortality and morbidity, in which risk stratification for adverse events is essential. N-terminal brain natriuretic peptide (NT-proBNP), a right ventricular dysfunction marker, may be useful in assessing the short-term prognosis of patients with PE.To characterize a sample of patients hospitalized with PE ...
Hélder, Dores +11 more
openaire +2 more sources
Emergency Medicine International, 2013 Background. The NT-ProBNP/BNP test has been validated as a marker for determining the etiology of acute dyspnea. In the setting of end-stage renal disease on hemodialysis (ESRD on HD), the utility of the NT-ProBNP/BNP test has not been validated.
Shaffer R. S. Mok +3 more
doaj +1 more source
BNP and NT-proBNP levels in patients with sepsis
Frontiers in Bioscience, 2013 Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent
Nan, Li +4 more
openaire +2 more sources
Folia Medica Indonesiana, 2017 Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP
Reine Risa Risthanti +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Few studies have directly compared the prognostic value of left ventricular ejection fraction (LVEF) and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) in patients with heart failure (HF) with reduced EF who have initiated guideline ...
Nandan Kodur +4 more
doaj +1 more source
Perioperative MedicineObjective We aimed to probe the clinical value of N-terminus pro-brain natriuretic peptide (NT-proBNP), myeloperoxidase (MPO), and neutrophil lymphocyte ratio (NLR) combined with echocardiography in the prediction of malignant arrhythmias (MA) in elderly
Jianping Liu +4 more
doaj +1 more source